(Post-pandemic Era)-Global Liquid Biopsy Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026

Report Code : XYZ2131739
Published On: Nov, 2020
Category : Medical Devices
Pages : 117

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research team published a report for global Liquid Biopsy market in this environment.

In terms of revenue, this research report indicated that the global Liquid Biopsy market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Liquid Biopsy industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The Biocept, Inc. aims at producing XX Liquid Biopsy in 2020, with XX % production to take place in global market, Qiagen N.V. accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Liquid Biopsy Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Liquid Biopsy Market
Biocept, Inc.
Qiagen N.V.
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini-Silicon Biosystems
Trovagene
Guardant Health
Mdxhealth
Genomic Health
Raindance Technologies
Thermo Fisher Scientific
Illumina

Major Type of Liquid Biopsy Covered in report:
Assays Kits
Instruments
Services
Application Segments Covered in report
Reference Laboratories
Hospitals and Physician Laboratories
Academic and Research Centers
Other End Users

For any other requirements, please feel free to contact us and we will provide you customized report.
With tables and figures helping analyze worldwide (Post pandemic Era) Global Liquid Biopsy market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Global Liquid Biopsy Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

1 Market Scope
1.1 Product Details and Introduction
1.1.1 Assays Kits -Product Introduction and Major Manufacturers
1.1.2 Instruments -Product Introduction and Major Manufacturers
1.1.3 Services -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

2 Global Liquid Biopsy Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)

3 Regional Market Analysis
3.1 China Liquid Biopsy Market
3.1.1 Top Companies leading Liquid Biopsy Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Liquid Biopsy Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Liquid Biopsy Market
3.2.1 Top Companies leading Liquid Biopsy Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Liquid Biopsy Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Liquid Biopsy Market
3.3.1 Top Companies leading Liquid Biopsy Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Liquid Biopsy Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Liquid Biopsy Market
3.4.1 Top Companies leading Liquid Biopsy Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Liquid Biopsy Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Liquid Biopsy Market
3.5.1 Top Companies leading Liquid Biopsy Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Liquid Biopsy Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Liquid Biopsy Market
3.6.1 Top Companies leading Liquid Biopsy Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Liquid Biopsy Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Liquid Biopsy Market
3.7.1 Top Companies leading Liquid Biopsy Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Liquid Biopsy Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)

4 Value Chain (Impact of COVID-19)
4.1 Liquid Biopsy Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Liquid Biopsy Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors

5 Regional Market Forecast (2021-2026)
5.1 Global Liquid Biopsy Sales and Growth Rate (2021-2026)
5.2 Global Liquid Biopsy Sales Value and Growth Rate (2021-2026)

6 Liquid Biopsy Competitive Analysis
6.1 Biocept, Inc.
6.1.1 Biocept, Inc. Company Profiles
6.1.2 Biocept, Inc. Product Introduction
6.1.3 Biocept, Inc. Liquid Biopsy Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Qiagen N.V.
6.2.1 Qiagen N.V. Company Profiles
6.2.2 Qiagen N.V. Product Introduction
6.2.3 Qiagen N.V. Liquid Biopsy Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Company Profiles
6.3.2 Roche Diagnostics Product Introduction
6.3.3 Roche Diagnostics Liquid Biopsy Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Bio-Rad Laboratories
6.4.1 Bio-Rad Laboratories Company Profiles
6.4.2 Bio-Rad Laboratories Product Introduction
6.4.3 Bio-Rad Laboratories Liquid Biopsy Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Myriad Genetics
6.5.1 Myriad Genetics Company Profiles
6.5.2 Myriad Genetics Product Introduction
6.5.3 Myriad Genetics Liquid Biopsy Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Menarini-Silicon Biosystems
6.6.1 Menarini-Silicon Biosystems Company Profiles
6.6.2 Menarini-Silicon Biosystems Product Introduction
6.6.3 Menarini-Silicon Biosystems Liquid Biopsy Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Trovagene
6.7.1 Trovagene Company Profiles
6.7.2 Trovagene Product Introduction
6.7.3 Trovagene Liquid Biopsy Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Guardant Health
6.8.1 Guardant Health Company Profiles
6.8.2 Guardant Health Product Introduction
6.8.3 Guardant Health Liquid Biopsy Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Mdxhealth
6.9.1 Mdxhealth Company Profiles
6.9.2 Mdxhealth Product Introduction
6.9.3 Mdxhealth Liquid Biopsy Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 Genomic Health
6.10.1 Genomic Health Company Profiles
6.10.2 Genomic Health Product Introduction
6.10.3 Genomic Health Liquid Biopsy Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
6.11 Raindance Technologies
6.12 Thermo Fisher Scientific
6.13 Illumina

7 Conclusion
The (Post pandemic Era) Global Liquid Biopsy Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

Report Objectives / Segmentation Covered :

By Companies / players:
By Regions:
By Type:
By Application:

Frequently asked questions(FAQ's):

What trends are influencing the growth of the (Post pandemic Era) Global Liquid Biopsy Market?

New players are entering the (Post pandemic Era) Global Liquid Biopsy Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.

What is the expected rate of growth in the (Post pandemic Era) Global Liquid Biopsy Market?

From 2024 to 2029, the (Post pandemic Era) Global Liquid Biopsy Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.

What does the future hold for the (Post pandemic Era) Global Liquid Biopsy Market?

As the shift to value addition continues, companies in the (Post pandemic Era) Global Liquid Biopsy Market face the dual challenge of improving interoperability to optimize performance and experience.

What are the top priorities for the growth of the (Post pandemic Era) Global Liquid Biopsy Market?

In this highly competitive and rapidly evolving (Post pandemic Era) Global Liquid Biopsy Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.